Thyroid storm is an acute and life threatening endocrine emergency. Tachycardia commonly arises in Thyroid storm and often result in rapid hemodynamic deterioration. Cardiogenic shock is one of the leading causes of mortality. There are several conventional forms of treatment including beta blocker, antithyroid drugs, iodine therapy, and glucocorticoids. Management of thyrotoxicosis-induced cardiogenic shock can be challenging, given that thionamides are slow acting and may cause serious liver damage and beta-blockers may have potentially negative inotropic effects. We report the first case of thyrotoxicosis-induced cardiogenic shock in which both amiodarone and cardiopulmonary supportive efforts were used to recovery from shock state without antithyroid drugs. This case emphasizes the crucial role of amiodarone as a bridge to recovery in Thyroid Storm.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Cardiac Failure
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect